Insider trade

Tyra Biosciences (TYRA): Director sold ~$177K

Nina S Kjellson, Director at Tyra Biosciences, sold ~$177K of Tyra Biosciences shares.

~$177K
Approx. value · 11K sh @ $16.46
461K
Holds after · shares reported
Traded
Oct 31, 2024
Filed
Nov 1, 2024

What stands out in this filing

  • The sale was 2.3% of the shares this insider held before it; the filing reports 461,457 shares, held indirectly afterwards.
  • 10,750 shares at an average of $16.46 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 30, 2024InsiderCEO sold ~$12K of TYRA shares in the open market
  2. Oct 15, 2024InsiderCEO sold ~$244K of TYRA shares in the open market
  3. Oct 16, 2024Insider · 1 personInsiders: 3 sales (~$871K)
  4. Oct 17, 2024Insider · 1 personInsiders: 2 sales (~$398K)
  5. Oct 18, 2024InsiderCEO sold ~$1.18M of TYRA shares in the open market
  6. Oct 21, 2024Insider · 1 personInsiders: 2 sales (~$532K)
  7. Oct 30, 2024Insider · 2 peopleInsiders: 1 purchase (~$152K), 2 sales (~$179K)
  8. Oct 31, 2024 · this disclosureInsiderDirector sold ~$177K of TYRA shares in the open market

What came next

  1. Oct 31, 2024InsiderDirector sold ~$1.47M of TYRA shares in the open market
  2. Nov 1, 2024Insider · 1 personInsiders: 4 sales (~$455K)
  3. Nov 4, 2024Insider · 1 personInsiders: 2 sales (~$18K)
  4. Nov 5, 2024Insider · 1 personInsiders: 2 sales (~$176K)
  5. Nov 6, 2024Insider · 1 personInsiders: 2 sales (~$902K)
  6. Nov 7, 2024Insider · 1 personInsiders: 2 sales (~$383K)
  7. Nov 8, 2024InsiderDirector purchased ~$19.8M of TYRA shares in the open market
  8. Nov 25, 2024Insider · 1 personInsiders: 2 sales (~$89K)
  9. Jan 16, 2025Insider · 1 personInsiders: 2 sales (~$127K)
  10. Jan 17, 2025Insider · 1 personInsiders: 2 sales (~$218K)
  11. Jan 21, 2025InsiderDirector sold ~$65K of TYRA shares in the open market
  12. Jan 23, 2025InsiderDirector sold ~$78K of TYRA shares in the open market
  13. Feb 5, 2025Insider · 1 personInsiders: 2 sales (~$74K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tyra Biosciences

OQRO holds no insider, Congress, fund or contract record for Tyra Biosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TYRA page.

Other recent filings by Nina S Kjellson, Director

The full history of Nina S Kjellson, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Tyra Biosciences (TYRA) insider traded, and how much?

Nina S Kjellson, Director at Tyra Biosciences, sold ~$177K of Tyra Biosciences shares. 11K shares at $16.46.

When did it happen, and when was it made public?

Traded: Oct 31, 2024. Filed: Nov 1, 2024. That is 1 day between the two dates.

What stands out in this filing?

The sale was 2.3% of the shares this insider held before it; the filing reports 461,457 shares, held indirectly afterwards. 10,750 shares at an average of $16.46 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean TYRA stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Tyra Biosciences

Everything OQRO holds on this company is on its TYRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data